Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, Salvia divinorum

article

Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, Salvia divinorum is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1021/JO00198A026
P5875ResearchGate publication ID231576754

P2093author name stringMasato Koreeda
William M. Butler
Ara G. Paul
George M. Hatfield
Leander J. Valdes
P433issue24
P407language of work or nameEnglishQ1860
P921main subjectsalvinorin BQ9333044
Salvia divinorumQ320584
salvinorin AQ413512
terpenoidsQ426694
P304page(s)4716-4720
P577publication date1984-11-01
P1433published inJournal of Organic ChemistryQ898967
P1476titleDivinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, Salvia divinorum
P478volume49

Reverse relations

cites work (P2860)
Q33719556A (-)-kolavenyl diphosphate synthase catalyzes the first step of salvinorin A biosynthesis in Salvia divinorum.
Q33973923Acute Physiologic and Chronic Histologic Changes in Rats and Mice Exposed to the Unique Hallucinogen Salvinorin A
Q38902043Clerodane diterpenes: sources, structures, and biological activities
Q28275440Collybolide is a novel biased agonist of κ-opioid receptors with potent antipruritic activity
Q47871946Depressant Effects of Salvia divinorum Involve Disruption of Physiological Sleep.
Q104391140High performance liquid chromatographic quantification of salvinorin a from tissues ofsalvia divinorum epling & játiva-m
Q36894509Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET.
Q36977483Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors.
Q34714459Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial
Q38778876Molecular Signaling Pathways Behind the Biological Effects of Salvia Species Diterpenes in Neuropharmacology and Cardiology
Q27300685Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans
Q37777404Natural Products from the Hallucinogenic Sage
Q105149391Neo-clerodane diterpenoids from Salvia madrensis
Q37660087New therapeutic potential for psychoactive natural products
Q42286399Novel neoclerodane diterpene derivatives from the smoke of salvinorin A
Q35840042Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin A
Q40585107Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A.
Q44641835Salvia divinorum use and phenomenology: results from an online survey
Q33913584Salvia divinorum: an hallucinogenic mint which might become a new recreational drug in Switzerland.
Q57888900Salvia divinorum: toxicological aspects and analysis in human biological specimens
Q24535736Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist
Q35082154Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptor
Q46333990Screening of Hallucinogenic Compounds and Genomic Characterisation of 40 Anatolian Salvia Species.
Q38976907Silver & gold-catalyzed routes to furans and benzofurans.
Q35887833Synthesis and biological evaluation of C-2 halogenated analogs of salvinorin A
Q24681800Synthetic studies of neoclerodane diterpenes from Salvia divinorum: exploration of the 1-position
Q48248296Total Synthesis of (-)-Salvinorin A.
Q79919819Unambiguous NMR spectral assignments of salvinorin A
Q37855806Utilizing nature as a source of new probes for opioid pharmacology

Search more.